Asthma News – July 21, 2021
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff.
Sign up to receive weekly-ish news emails.
Check out the most recent
MDHHS asthma social media messages and share them with your networks.
We are interested in how primary care providers communicate with parents, school staff and school-based providers about children with illnesses that require daily medications and/or have chronic conditions that require care at school by nurses or school staff.
Survey closes July 23.
The Michigan Dept. of Health & Human Services Asthma Program has posted a new strategic plan to the GetAsthmaHelp.org website. It will guide surveillance, partnership and intervention efforts until 2025. Thanks to all who contributed!
Asthma-related social media messages are now available, please share them within your personal or organizational networks!
The Centers for Disease Control & Prevention has developed a new infographic about ACEs to help promote understanding, prevent childhood adversities and help children thrive.
Because of the COVID-19 pandemic, the federal government has opened up a special enrollment period which runs until August 15, 2021 in most states. Please share with those in need of insurance.
A new study found that 21% of Dutch asthma study participants did not use short-acting beta-agonists (SABA), 19% used SABA 1 to 2 times and 60% used SABA ≥ 3 times (high SABA users) in the last week. High SABA users more frequently used antibiotics and oral steroids, more frequently visited the emergency departments or needed an overnight hospital stay.
ALA tracks the coverage and related barriers to asthma guidelines-based care in state Medicaid programs to improve access to guidelines-based care and improve asthma outcomes by understanding the gaps between best practices in improving asthma outcomes and what is actually being covered by payers, including Medicaid, and implemented by providers.
More about this initiative.
Researchers in Sweden have developed a non-invasive urine-based test that can identify what type of asthma a patient has and its severity. If developed into a clinical laboratory diagnostic, such a test also could give clinicians a better idea of what treatment is more likely to be effective—a core goal of precision medicine.